Top stories

The Big Read

Business

SpaceX Earned $4.4 Billion in the Third Quarter, $1.6 Billion of It Outside Operations. Musk Says SpaceX and Tesla Have Each Formed a Merger Committee.

The profit is real, but more than a third of it did not come from operations. The more consequential numbers are $19.6 billion of capital spending in one quarter and a merger idea that would need a majority of all Tesla shares.

An aerial view of a coastal launch site with a tall stainless-steel rocket standing beside tank farms and buildings, with tidal flats and the sea beyond.

SpaceX's launch site at Starbase, on the Texas coast, photographed in an earlier year with a Starship prototype on the pad. File photograph.

SpaceX reported third-quarter net income of $4.404 billion on Tuesday 20 October, of which $2.791 billion came from operations, and Elon Musk said on the earnings call that SpaceX and Tesla have formed special committees to discuss combining.

Revenue was $14.575 billion, up 161 per cent from $5.576 billion a year earlier, according to the results release SpaceX furnished to the SEC. That beat the $12.7 billion Bloomberg consensus cited by Yahoo Finance. The profit headline needs a footnote. The merger remark needs a bigger one.

About 63 per cent. Income from operations was $2.791 billion. The remaining $1.613 billion of net income came from interest income of $873 million, other income of $1.025 billion and a $390 million income tax benefit, less $675 million of interest expense. By this publication's arithmetic, that is 36.6 per cent of the quarter's net income. A year earlier the company posted a net loss of $1.054 billion, after a $562 million tax charge.

Continue reading …

Opinion

What’s News

More News
Got a tip for us?

Editors read every submission. Here is how to send documents, on background or on the record.

How to submit

The Picture

Two machined metal flanges resting on engineering drawings.
Machined metal parts on technical drawings. New orders at New York State manufacturers rose 21 points in October. File photograph.

New York Factories Posted Their Best Reading Since December 2021, 25.5. Delivery Times Are Lengthening, Supply Is the Scarcest Since 2022, and Hiring Is Only Modest.

Editor's Choice

Latest News

Everything we have published, newest first

Business

Truist Is Selling $7.7 Billion of LightStream Loans to Carlyle, Weeks After Shedding $5.5 Billion of Auto Loans. It Also Took a $1.45 Billion Securities Loss.

Truist agreed on 14 October to sell $7.7 billion of unsecured consumer loans, substantially all of LightStream's assets, to Carlyle. Its third-quarter results on Friday 16 October showed reported earnings of $0.56 a share and adjusted earnings of $1.16, after a $1.447 billion pre-tax loss on the sale of securities.

By Margaret Holloway  

The Charlotte, North Carolina, skyline seen from the west above trees in spring.
Business

McKesson Is Paying $1.4 Billion for Half of Option Care. The Deal Sets Up a Framework for It to Buy the Rest.

Clayton Dubilier & Rice and McKesson agreed on Monday to take Option Care Health, the largest independent home infusion company in the United States, private for $32.05 a share. McKesson is putting in about $1.4 billion for 49 per cent, and the agreement sets out a framework for it to buy the private equity firm's majority later. Lenders have committed more money to the deal than the two buyers have.

A bag of blood with a drip chamber and tubing hanging from a stand in a clinical setting.
Yellow fibre-optic patch cables plugged into rows of green connectors in a network cabinet.
Technology

Thoma Bravo's Proofpoint Will Pay $6.3 Billion in Cash for Varonis at $49.75 a Share. The Premium Is 52 Per Cent Against June and 17 Per Cent Against September.

Proofpoint, a Thoma Bravo portfolio company, agreed on Thursday 15 October to buy Varonis Systems for $49.75 a share in cash, a deal valued at about $6.3 billion. Varonis would owe a $211.7 million termination fee in some cases; Proofpoint would owe $423.3 million in others. Closing is expected in the first half of 2027 and needs a Varonis shareholder vote and regulatory approvals.

By Alison Acosta  

World

AT&T Will Sell Its Mexican Wireless Business for $2 Billion, About 0.4 Times Its 2025 Revenue. The Buyers Plan to Borrow Up to $1.4 Billion of the Price.

AT&T said on Tuesday 13 October that it will sell AT&T Mexico to a consortium owned equally by Grupo Televisa and Fintech Holdings for $2 billion in cash at closing, subject to adjustments. A Televisa filing shows the buyers plan to borrow up to $1.4 billion and that Televisa will put in $400 million. Closing is expected in the first quarter of 2027, subject to Mexican regulatory approvals.

By Thomas Gutierrez  

The Mexico City skyline seen over the rooftops of Colonia Condesa, with towers on Paseo de la Reforma under a cloudy sky.
The Numbers

Industrial Production Rose 0.7 Per Cent in September, and Utilities Supplied More of It Than Factories. Manufacturing Rose 0.3 Per Cent and Is Up 1.1 Per Cent in a Year.

The Federal Reserve said on Friday 16 October that industrial production rose 0.7 per cent in September after a 0.1 per cent gain in August. Utilities output rose 3.5 per cent, manufacturing 0.3 per cent and mining 0.2 per cent. Capacity utilization rose to 76.9 per cent, 2.5 points below its long-run average.

By Daniel Okafor  

What We’re Following

View all

Health

One Research Firm Puts Regenerative Medicine at $41 Billion, Heading for $162 Billion. Dr. David Borenstein on Why the FDA Keeps Cracking Down on Unproven Clinics.

DelveInsight, a market-research firm, estimates the global regenerative medicine market at about $41 billion in 2025 and projects roughly $162 billion by 2034. The FDA has spent years pursuing clinics selling unapproved stem cell products, most recently in a January 2025 warning letter to a Pompano Beach, Florida manufacturer. Dr. David Borenstein, a physician who offers regenerative treatments, says patients should ask what a product is before they book.

By Thomas Gutierrez  

A culture growing on agar in a petri dish, lit from below in a laboratory.
More Stories

Opinion Voices

Argument and analysis from our columnists

Featured Voices

The reporters and editors behind the coverage

The Story So Far

The Hormuz Closure28 stories

The Cranberry Brief

Reporting on business, technology and power, each weekday morning.

We’ll only use your address to send The Cranberry Brief. Unsubscribe anytime. Read our privacy policy.